Stock Analysts

Will Philip Morris’ Efforts to Expand RRPs Fuel Growth?

As smoking rate continues to decline globally along with stringent government regulations and increasing consumer health awareness, Philip Morris International Inc. PM has been facing receding volumes in its combustible products category. Amid such conditions, the company has been striving to achieve growth and stay afloat in the industry by focusing on reduced-risk tobacco products. […]

Economic Data

Fed Chair Powell: The Congress-Whisperer?

Tuesday, February 27, 2018 Fed Chair Jay Powell looks to ease tensions in his first appearance before U.S. Congress this morning. Amid a month of sometimes wild market volatility based on inflation/interest rate hikes at the Federal Reserve, Powell's written statement brings a calm approach in presenting his view of the domestic economy: “monetary policy moves are helpful,” “inflation is low and stable,” “exports and fiscal policy are now market headwinds” and, perhaps most importantly, he expects “further gradual rate increases” going forward. […]

Technicals

Eaton Vance (EV) Beats on Q1 Earnings & Revenue Estimates

Have you been eager to see how Eaton Vance Corp. EV performed in first-quarter fiscal 2018 (ended Jan 31) in comparison with the market expectations? Let’s quickly scan through the key facts from this Massachusetts-based investment management firm’s earnings release this morning: An Earnings Beat Eaton Vance came out with adjusted earnings per share of 78 cents, beating the Zacks Consensus Estimate of 71 cents […]

Technicals

Marriott Vacations (VAC) Beats on Q4 Earnings, Revenues Lag

Marriott Vacations Worldwide Corporation VAC operates as a vacation ownership company. The company markets and manages vacation ownership and related products under the Marriott Vacation Club and Grand Residences by Marriott brands, The Ritz-Carlton Destination Club brand, The Ritz-Carlton Residences brand. Marriott Vacations continues to benefit from positive timeshare industry trends and has been able to maintain a steady flow of clients by offering tours to diverse locations and programs with greater outreach. […]

Stock Analysts

Lilly’s Verzenio Wins FDA Nod for First Line Breast Cancer

Eli Lilly and Company LLY announced that its new advanced breast cancer treatment Verzenio (abemaciclib) has gained FDA approval in first-line setting. With the latest approval, Verzenio is approved in combination with an aromatase inhibitor (AI -either anastrozole or letrozole) as initial endocrine-based therapy in postmenopausal women with HR+, HER2- advanced/metastatic breast cancer who have had no prior systemic treatment for the advanced disease. Lilly’s shares have declined 5% this year so far while the industry recorded an increase of 0.8% […]

Stock Analysts

Is Bed Bath & Beyond (BBBY) a Great Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]